> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Support for OTC Monograph Legislation
- URL: https://www.fdaweb.com/support-for-otc-monograph-legislation/
- Published: 2019-01-09T12:00:00.000Z
- Updated: 2026-09-15T00:53:29.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5143115

The Consumer Healthcare Products Association (CHPA) says it applauds introduction and passage of H.R. 269, which includes the Over-the-Counter Monograph Safety, Innovation, and Reform Act. The bipartisan measure was approved in the House on a 401-17 vote. CHPA says this is the third time the House has approved such legislation.

“This legislation has received overwhelmingly bipartisan support because it would make commonsense regulatory reforms to increase the efficiency and responsiveness necessary to protect consumer health and spur innovation,” says CHPA CEO **Scott Melville**. “We are encouraged that the momentum behind monograph reform is carrying over into the new Congress.”

CHPA says the current OTC monograph system relies on notice and comment rulemaking that “has become an increasingly slow and unresponsive administrative process. As a result, the monograph system has become cumbersome and, essentially, has ground to a halt. Today it can take several years or more to update product labels with new safety information, approve new ingredients, or make other important changes for consumers. Moreover, the current system does not provide a mechanism for innovation.”